Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada

References

• 1. Maruf AA, Bousman CA. Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic. Psychiatry Clin. Neurosci. Rep. 1(2), 1–11 (2022).
  Google Scholar
• 2. Bousman CA, Maruf AA, Marques DF, Brown LC, Müller DJ. The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review. Psychol. Med. 53(16), 1–11 (2023).
  Google Scholar
• 3. Memphis. Implementation. Clinical Pharmacogenetics Implementation Consortium. Tennessee, USA (2024). https://cpicpgx.org/implementation/
  Google Scholar
• 4. Haidar C-E, Petry N, Oxencis C, Douglas JS, Hoffman JM. ASHP Statement on the pharmacist's role in clinical pharmacogenomics. Am. J. Health Syst. Pharm. 79(8), 704–707 (2022).
  MedlineGoogle Scholar
• 5. Maruf AA, Aziz MA. The potential roles of pharmacists in the clinical implementation of pharmacogenomics. Pharmacy (Basel) 11(6), 180 (2023).
  MedlineGoogle Scholar
• 6. Haga SB. The critical role of pharmacists in the clinical delivery of pharmacogenetics in the U.S. Pharmacy 11(5), 144 (2023).
  MedlineGoogle Scholar
• 7. Hayashi M, Hamdy DA, Mahmoud SH. Applications for pharmacogenomics in pharmacy practice: a scoping review. Res. Social Adm. Pharm. 18(7), 3094–3118 (2022).
  MedlineGoogle Scholar
• 8. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison KJ, Bousman CA. Pharmacogenetic testing options relevant to psychiatry in Canada. Can. J. Psychiatry 65(8), 521–530 (2020).
  MedlineGoogle Scholar
• 9. Haga SB, Kantor A. Horizon scan of clinical laboratories offering pharmacogenetic testing. Health Aff. (Millwood) 37(5), 717–723 (2018).
  MedlineGoogle Scholar
• 10. Wondrasek A, Fryza A, Aziz MA, Leong C, Kowalec K, Maruf AA. Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: a systematic review. Health Sci. Rep. 7(1), e1844 (2024).
  MedlineGoogle Scholar
• 11. Hayashi M, Bousman CA. Experience, knowledge, and perceptions of pharmacogenomics among pharmacists and nurse practitioners in Alberta hospitals. Pharmacy 10(6), 139 (2022).
  MedlineGoogle Scholar
• 12. de Denus S, Letarte N, Hurlimann T et al. An evaluation of pharmacists' expectations towards pharmacogenomics. Pharmacogenomics 14(2), 165–175 (2013).
  CASGoogle Scholar
• 13. Meloche M, Kwon HJ, Letarte N et al. Opinion, experience and educational preferences concerning pharmacogenomics: an exploratory study of Quebec pharmacists. Pharmacogenomics 21(4), 235–245 (2020).
  CASGoogle Scholar
• 14. Petit C, Croisetière A, Chen F, Laverdière I. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice. Pharmacogenomics 21(4), 247–256 (2020).
  CASGoogle Scholar
• 15. Canadian Pharmacists Association (CPhA). Scope of Practice–English (2024). www.pharmacists.ca/advocacy/scope-of-practice/
  Google Scholar
• 16. Atkins L, Francis J, Islam R et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement. Sci. 12(1), 77 (2017).
  MedlineGoogle Scholar
• 17. Jessel CD, Al Maruf A, Oomen A, Arnold PD, Bousman CA. Pharmacogenetic testing knowledge and attitudes among pediatric psychiatrists and pediatricians in Alberta, Canada. J. Can. Acad. Child Adolesc. Psychiatry 31(1), 18–27 (2022).
  MedlineGoogle Scholar
• 18. Harris PA, Taylor R, Minor BL et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inform. 95, 103208 (2019).
  MedlineGoogle Scholar
• 19. Gammal RS, Mayes J, Caudle KE. Ready or not, here it comes: direct-to-consumer pharmacogenomic testing and its implications for community pharmacists. J. Am. Pharm. Assoc. 59(5), 646–650 (2019).
  Google Scholar
• 20. Crown N, Sproule BA, Luke MJ, Piquette-Miller M, McCarthy LM. A continuing professional development program for pharmacists implementing pharmacogenomics into practice. Pharmacy (Basel) 8(2), 55 (2020).
  MedlineGoogle Scholar
• 21. Luke MJ, Krupetsky N, Liu H et al. Pharmacists as personalized medicine experts (PRIME): experiences implementing pharmacist-led pharmacogenomic testing in primary care practices. Pharmacy (Basel) 9(4), 201 (2021).
  MedlineGoogle Scholar
• 22. Breaux S, Desrosiers FAD, Neira M, Sinha S, Nislow C. Pharmacogenomics at the point of care: a community pharmacy project in British Columbia. J. Pers. Med. 11(1), 11 (2020).
  MedlineGoogle Scholar
• 23. Hayashi M, Mahmoud SH, Hamdy DA. The efficacy of a didactic and case-based pharmacogenomics education program on improving the knowledge and confidence of Alberta pharmacists. Pharmgenomics Pers. Med. 15, 409–427 (2022).
  MedlineGoogle Scholar
• 24. Pharmacogenomics for Community Pharmacists Online Version. Pharmacy Association of Nova Scotia. Dartmouth, NS (2024). https://pans.ns.ca/pharmacy-professionals/professional-development/online-courses/pharmacogenomics-community-1
  Google Scholar
• 25. Pharmacogenomics Knowledgebase (PharmGKB). Educational resources for PharmGKB and PGxP (2024). www.pharmgkb.org/page/educationalResources
  Google Scholar
• 26. Alhaqan A, Smith F, Bates I. A global evidence review of systemic factors influencing participation in pharmacy professional development activities. Res. Soc. Adm. Pharm. 17(3), 488–496 (2021).
  MedlineGoogle Scholar
• 27. Frigon M-P, Blackburn M-È, Dubois-Bouchard C, Gagnon A-L, Tardif S, Tremblay K. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics 20(8), 589–598 (2019).
  CASGoogle Scholar
• 28. Morris SA, Alsaidi AT, Verbyla A et al. Cost effectiveness of pharmacogenetic testing for drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines: a systematic review. Clin. Pharmacol. Ther. 112(6), 1318–1328 (2022).
  Medline CASGoogle Scholar
• 29. Ghanbarian S, Wong GWK, Bunka M et al. Cost-effectiveness of pharmacogenomic-guided treatment for major depression. CMAJ 195(44), E1499–E1508 (2023).
  MedlineGoogle Scholar
• 30. Jennifer Paterson. Pharmacogenetic testing a growing area as pilot projects, research get underway (2018). www.benefitscanada.com/news/bencan/pharmacogenetics-testing-offering-opportunities-in-disability-drug-cost-management/
  Google Scholar
• 31. Resolute Legal Disability Lawyers. Long-term disability and pharmacogenomic testing (2022). www.resolutelegal.ca/long-term-disability-and-pharmacogenomic-testing/
  Google Scholar
• 32. Kastrinos A, Campbell-Salome G, Shelton S, Peterson EB, Bylund CL. PGx in psychiatry: patients' knowledge, interest, and uncertainty management preferences in the context of pharmacogenomic testing. Patient Educ. Couns. 104(4), 732–738 (2021).
  MedlineGoogle Scholar
• 33. More patients, pharmacists adopting pharmacogenomics. BC Pharmacy Association (2019). www.bcpharmacy.ca/tablet/fall-19/more-patients-pharmacists-adopting-pharmacogenomics
  Google Scholar
• 34. Huston SA, Zdanowicz MM, Fetterman JW. Pharmacogenomics in advanced pharmacy practice experiences. Curr. Pharm. Teach. Learn. 2(4), 196–203 (2010).
  Google Scholar
• 35. Cohn I, Cohn RD, Ito S. Professional opportunity for pharmacists to integrate pharmacogenomics in medication therapy. Can. Pharm. J. (Ott.) 151(3), 167–169 (2018).
  MedlineGoogle Scholar
• 36. Kabbani D, Akika R, Wahid A, Daly AK, Cascorbi I, Zgheib NK. Pharmacogenomics in practice: a review and implementation guide. Front. Pharmacol. 14 (1189976), 1–23 (2023).
  Google Scholar
• 37. Reiss SM. American Pharmacists Association. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J. Am. Pharm. Assoc. 51(6), e64–e74 (2011).
  MedlineGoogle Scholar
• 38. 2022 Health Technology Trends to Watch. Canadian Agency for Drugs and Technologies in Health (2022). www.cadth.ca/2022-health-technology-trends-watch-0
  Google Scholar